Houston

Survey Finds Nearly 1 in 2 Americans are Concerned About Contracting an Infectious Disease from a Hospital

Retrieved on: 
Thursday, November 9, 2023
Woman, Hispanic, Ageing, Infection, Auris, Black people, Fear, YouGov, Disinfectant, Houston, White, Fungal infection, Risk, Hospital, Centers for Disease Control and Prevention, Patient, Health insurance, Nursing, Birth control, White people

The findings, which arrive on the heels of the pandemic and amidst an escalating infectious disease crisis, reflect consumer sentiment and concerns when seeking medical care.

Key Points: 
  • The findings, which arrive on the heels of the pandemic and amidst an escalating infectious disease crisis, reflect consumer sentiment and concerns when seeking medical care.
  • Sixty-eight percent (68%) of Americans expressed concern about the cleanliness of surfaces in a hospital, with 31% noting they are very concerned.
  • Findings also show that younger Americans and women generally harbor greater concerns about hospital infections and cleanliness than older Americans or men.
  • Fifty-one percent (51%) of women said they may contract an infectious disease from a hospital room, compared to only 41% for men.

Anima Biotech Partners with BioSpace to Present Its Latest Webinar in the LightON mRNA Biology Masterclass

Retrieved on: 
Monday, November 6, 2023
GEN, Houston, Therapy, Assistant, RNA, Tech, Mary Ann Liebert, Inflammation, News, Genetic engineering, RBP, Partnership, Messenger, Cancer, Vaccine

BERNARDSVILLE, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, announced its third webinar, a part of their exclusive LightON mRNA | mRNA Biology Masterclass series partnered with leading life science media outlets.

Key Points: 
  • BERNARDSVILLE, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, announced its third webinar, a part of their exclusive LightON mRNA | mRNA Biology Masterclass series partnered with leading life science media outlets.
  • The mRNA Biology Masterclasses latest webinar, titled, “mRNA is Never Naked, Exploring RBP Target Space & Therapeutic Opportunities,” in partnership with BioSpace will take place on November 14th at 11:00 AM EST.
  • The webinar will explore the role of RNA binding proteins (RBPs), key regulators of mRNA biology that are found to be dysregulated in many diseases including cancer, neurodegeneration, and inflammation.
  • Anima’s LightON mRNA | mRNA Biology Masterclass webinar series, aims to educate on various topics within the mRNA regulatory space.

New Hospital Safety Grades from The Leapfrog Group Find Improved Infection Rates Following Major Spike During COVID-19 Pandemic

Retrieved on: 
Monday, November 6, 2023
Patient, Staphylococcus aureus, Patient safety organization, Infection, Houston, CLABSI, COVID-19, Medicine, MRSA, Binder, Hospital, Accident, Catheter-associated urinary tract infection, Approximation error, Movement, The Post-Pandemic World Order, Communication, Letter, Dentistry, Nursing, CAUTI

WASHINGTON, Nov. 6, 2023 /PRNewswire/ -- The Leapfrog Group, an independent national nonprofit driving a movement for patient safety, today released its fall 2023 Hospital Safety Grades, assigning a letter grade to nearly 3,000 general hospitals on how well they prevent medical errors, accidents and infections. The latest grades show hospitals reducing health care-acquired infections (HAIs) post-pandemic after significant increases in infection rates during the COVID-19 pandemic. This cycle, nearly 30% of hospitals earned an "A," 24% earned a "B," 39% earned a "C," 7% earned a "D" and less than 1% earned an "F."

Key Points: 
  • The latest grades show hospitals reducing health care-acquired infections (HAIs) post-pandemic after significant increases in infection rates during the COVID-19 pandemic.
  • The Leapfrog Hospital Safety Grade also includes five patient experience measures that evidence suggests are closely associated with patient safety issues.
  • The Leapfrog Hospital Safety Grade is the only hospital ratings program based exclusively on hospital prevention of medical errors and harms to patients.
  • For more information about the Hospital Safety Grades, including details on individual hospital grades and state rankings, please visit HospitalSafetyGrade.org .

Highlight from Kinnos Recognized as One of TIME’s Best Inventions of 2023

Retrieved on: 
Tuesday, October 24, 2023
Auris, TIME, Invention, Fast, Infection, Houston, Design, Fungal infection, Hospital, Ebola, Patient, Pharmaceutical industry, Vaccine

BROOKLYN, N.Y., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Kinnos today announced that Highlight®, its novel technology for colorizing disinfectant wipes, earned a special mention in the TIME Best Inventions of 2023 list.

Key Points: 
  • BROOKLYN, N.Y., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Kinnos today announced that Highlight®, its novel technology for colorizing disinfectant wipes, earned a special mention in the TIME Best Inventions of 2023 list.
  • New threats like Candida auris continue to emerge just as multiple studies show that less than 50% of hospital surfaces are properly cleaned.
  • The result is a list of inventions that are changing how we live, work, play, and think about what’s possible.
  • Highlight from Kinnos was also recently recognized in the Fast Company 2023 Innovation by Design awards.

Highlight for Wipes from Kinnos Named Finalist in 2023 Fierce Innovation Awards

Retrieved on: 
Tuesday, October 17, 2023
Infection, Hospital, Fast, Disinfectant, Infection Control & Hospital Epidemiology, Disease, Fungal infection, Wet wipe, Houston, Design, Patient, Pharmaceutical industry

BROOKLYN, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Kinnos today announced that Highlight® for Wipes, its novel technology for colorizing disinfectant wipes, was named a finalist in the 2023 Fierce Innovation Awards: Life Sciences Edition.

Key Points: 
  • BROOKLYN, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Kinnos today announced that Highlight® for Wipes, its novel technology for colorizing disinfectant wipes, was named a finalist in the 2023 Fierce Innovation Awards: Life Sciences Edition.
  • Fierce Innovation Awards showcase innovations that have made an impact over the last 12 months and represent the greatest potential to transform the industry.
  • Highlight from Kinnos was recently recognized in the Fast Company 2023 Innovation by Design awards.
  • Winners of the Fierce Innovation Awards will be announced on November 29th in the company’s Innovation Report.

CORRECTION: Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New England Journal of Medicine

Retrieved on: 
Wednesday, October 11, 2023
Chlorhexidine, Infection, Methicillin-resistant Staphylococcus aureus, Nursing, Doctor of Philosophy, The New England Journal of Medicine, Prevalence, Epidemiology, UCI, Hospital, MPH, University of California, Irvine, University, CDC, Agency for Healthcare Research and Quality, University of California, Irvine School of Medicine, Health, Harbor–UCLA Medical Center, AHRQ, MHSA, Nursing home, Fungal infection, Long-term care, MRSA, Povidone-iodine, Houston, Clinical trial, Nose, Institute of Health and Biomedical Innovation, Korea Disease Control and Prevention Agency, Skin, UCI School of Biological Sciences, Urinary tract infection, Enterococcus-1 RNA motif, Bed, Research, NIH, Pharmaceutical industry, MD, Medicine

The findings were published on October 10, 2023, in the New England Journal of Medicine.

Key Points: 
  • The findings were published on October 10, 2023, in the New England Journal of Medicine.
  • “The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.
  • Dr. Miller is the Chief of Infectious Diseases at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Torrance, California.
  • “Nursing Home Decolonization for Infection and Hospitalization Prevention” published in the New England Journal of Medicine on October 10, 2023: https://www.nejm.org/doi/full/10.1056/NEJMoa2215254?query=featured_home

Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New English Journal of Medicine

Retrieved on: 
Tuesday, October 10, 2023
Chlorhexidine, Infection, Methicillin-resistant Staphylococcus aureus, Nursing, Doctor of Philosophy, The New England Journal of Medicine, Prevalence, Epidemiology, UCI, Hospital, MPH, University of California, Irvine, CDC, University, Agency for Healthcare Research and Quality, University of California, Irvine School of Medicine, Health, Harbor–UCLA Medical Center, AHRQ, MHSA, Fungal infection, Long-term care, MRSA, Povidone-iodine, Houston, Clinical trial, Nose, Institute of Health and Biomedical Innovation, Korea Disease Control and Prevention Agency, Skin, UCI School of Biological Sciences, Urinary tract infection, Enterococcus-1 RNA motif, Bed, Research, NIH, Pharmaceutical industry, MD, Medicine

“The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.

Key Points: 
  • “The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.
  • Dr. Miller is the Chief of Infectious Diseases at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Torrance, California.
  • Each year, 3 million healthcare-associated infections (HAIs) such as methicillin-resistant Staphylococcus aureus (MRSA), bloodstream and urinary tract infections occur in U.S. nursing homes.
  • The findings add to a growing body of Dr. Miller’s research that has been funded by NIH, AHRQ, and other federal sources.

North America Leads the Global Industrial and Institutional Cleaning Chemicals Market With Over 32% Revenue Share, Followed by APAC - ResearchAndMarkets.com

Retrieved on: 
Monday, October 16, 2023
Chemicals, Plastics, Manufacturing, School, Hospital, Urbanization, Restaurant, Risk, Development, Industrialisation, Disease, Private law, Adhesive, Growth, Houston, Hygiene, Detergent, Fungal infection, Infection, Water, Renewable energy, Pharmaceutical industry

The general-purpose cleaners segment is expected to dominate the global industrial and institutional cleaning chemicals market.

Key Points: 
  • The general-purpose cleaners segment is expected to dominate the global industrial and institutional cleaning chemicals market.
  • Surfactants are projected to be the largest segment in the global industrial and institutional cleaning chemicals market by raw materials.
  • North America leads the global industrial and institutional cleaning chemicals market, accounting for over 32% of revenue in 2022.
  • The global industrial and institutional cleaning chemicals market is highly competitive, with a mix of international and regional players.

BioVigil Action Replay feature shows individual hand hygiene activity, enables better contact tracing for infection prevention

Retrieved on: 
Monday, October 16, 2023
Animation, Action Replay, LeapFrog Enterprises, Hand, Houston, ANN, Nursing

The Action Replay feature uses animation to show a health provider's hand washing compliance journey and identify where cross contamination may have occurred.

Key Points: 
  • The Action Replay feature uses animation to show a health provider's hand washing compliance journey and identify where cross contamination may have occurred.
  • The system collects many data points including time in room, time from room entry to hand hygiene, and number of hand hygiene opportunities.
  • The Action Replay feature brings those data points to life by showing a longitudnal visual representation of each badge-wearer's hand hygiene activity within the patient room(s).
  • The Action Replay feature is part of a complete electronic hand hygiene system including a room sensor, sink sensor, badge sensor and robust data suite.

THE LAS VEGAS REVIEW-JOURNAL NAMES NEW SENIOR VICE PRESIDENT OF ADVERTISING SALES

Retrieved on: 
Thursday, October 12, 2023
Sentinel, Hearst Communications, Tribune Media, Star, Las Vegas Review-Journal, Television, Advertising, Houston, Star Tribune, LAS, Lee Enterprises, Houston Chronicle, Sun-Sentinel, WB, Chase, Publication, Giuseppe Labonia, Loyola University, San Francisco Chronicle, City, ABC, Management

LAS VEGAS, Oct. 11, 2023 /PRNewswire/ -- Longtime media executive Michael LaBonia was named senior vice president of advertising sales, effective immediately, Keith Moyer, publisher and editor of the Las Vegas Review-Journal, announced Tuesday.

Key Points: 
  • LAS VEGAS, Oct. 11, 2023 /PRNewswire/ -- Longtime media executive Michael LaBonia was named senior vice president of advertising sales, effective immediately, Keith Moyer, publisher and editor of the Las Vegas Review-Journal, announced Tuesday.
  • A former Hearst Media executive, LaBonia will succeed Chase Rankin, who accepted the role of president of Lee Enterprises' Western Division earlier this month.
  • LaBonia served as senior vice president of advertising for Hearst Newspapers and chief revenue officer and executive vice president of advertising for the Houston Chronicle.
  • LaBonia previously served as senior vice president of advertising at the San Francisco Chronicle, senior vice president of sales and strategic development in Minneapolis at the Star Tribune, and vice president of the Sun Sentinel in Fort Lauderdale, Florida.